FDA Investigator Daniel W Johnson
Daniel W Johnson has conducted inspections on 134 sites in 2 countries as of 03 Mar 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
134
Last Inspection Date:
03 Mar 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with Daniel W Johnson:
Abdellah El Hajjam,
Alan D Centi,
Albert A Salvador,
Alfred Puglia,
Althea A Williams,
Amanda M Osteen,
Amy L Mcintyre,
Anastasia M Shields,
Andrew I Carr,
Andrew T Todd,
Anita R Michael,
Ann L Demarco,
Ann Marie Karnick,
Anna Lazar,
Anne E Johnson,
Anthony M Criscuolo, Jr,
Antoinette L Ravelli,
Audrey Thereset Uy,
Avery J Dennis,
Barbara A Gullick,
Barbara J Maulfair,
Brandi L Garbutt,
Brandon J Brookens,
Brian D Young,
Brian S Keefer,
Bruce C Kovak,
Cara M Minelli,
Carol A Perry,
Cary Greene,
CDR Michael J Mero,
Celia L Hutchinstein,
Chad W Rice,
Christina K Theodorou,
Christopher Bastedo,
Craig D Zagata,
Craig W Swanson,
Crayton Lee,
Crystal A Harlan,
Cynthia White,
Daniel T Lee,
Dauksism,
David A Oluwo,
David A Schwartz,
David J Hafner,
David L Pearce,
David P Rice, Jr,
David W Johnson,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Debra J Bennett,
Denise M Digiulio,
Derek S Dealy,
Devon Jenkins,
Dhaval H Patel,
Donyel M Jones,
Edward D Mcdonald,
Edward P Potter,
Edwin L Hobbs,
Emily A Walters,
Eric L Vangraafeiland,
Eric Rothschild,
Erika M Wilkerson,
Erin D Mccaffery,
Gale L Glinecki,
Gayle S Lawson,
Gerald W Kopp,
Gianine E Tompkins,
Gregory E Beichner,
Hala L Selby,
James P Mcevoy,
Janet L Bowen,
Jason M Sluzynski,
Jeannie R Mayberry,
Jeen S Min,
Jeffrey J Thibodeau,
Jennifer A Bazergui,
Jessica D Nanini,
Jessica M Monteiro,
Joseph Brady,
Joseph S Fanelli,
Joseph T Dougherty,
Joshua C Schafer,
Judith A Paterson,
Julianne C Mccullough,
Justin A Hefferman,
Justin B Holder,
Karen A Spencer,
Karen F Tomaziefski,
Karyn M Campbell,
Kelly Doremus,
Kendra L Brooks,
Kerry A Kurdilla,
Kim G Campbell,
Kimberly A Dux,
Kish Bolden,
Kristen D Evans,
Kristina J Donohue,
Krystal O Ogunremi,
Kwong P Lee,
Kyle D Covill,
Kyle S Hobson,
Laishan L Lam,
Latoya S Oliver Powell,
Lawrence R Johnson,
LCDR Margaret Edi Gennaro,
Linda M Hoover,
Linda M Ross,
Linda S Mattingly,
Lisa B Orr,
Lori A Rose,
Louis Christy,
LT John M Mastalski,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Magda M Karlsen,
Magdi Ali,
Margaret A Smithers,
Marjorie D Schultz,
Mark P Prusak,
Martha Sullivan Myrick,
Matthew R Noonan,
Maureen A Duckworth,
Maureen A Wentzel,
Megan F Mclaughlin,
Megan M Lauff,
Melinda L Rice,
Melissa B Libby,
Melissa M Dauksis,
Melissa M Schafer,
Meredith L Sheridan,
Michael A Taylor,
Michael D Ellison,
Michael J Nerz,
Michael Rosner,
Michele M Falchek,
Nancy L Rose,
Nancy M Lazzari,
Nicholas J Morici,
Nikisha M Bolden,
Paul E Stein,
Rachele A Saisselin,
Raffi B Papazian,
Raymond L Cheung,
Rhonda J Walley,
Richard D Manney,
Robert B Shibuya, MD,
Robert W Calais,
Ronald A Stokes,
Ronald T Colucci,
Russell P Vandermark,
Ruth A Oni,
Sarah J Park,
Sarah K Lemin,
Sean D Duke,
Seng Ching Hwang,
Shannon A Dinardo,
Sharon Mills,
Sherri J Liu,
Stephanie Mangigian, MS/OSH, RN,
Steven E Kane,
Susan F Laska, MS,
Tamara N Champion,
Tammy M Phillips,
Tania E Vizcaino,
Teigan M Mule,
Tekalign Wondimu,
Thomas E Friel,
Thomas J Mooney,
Todd J Maushart,
Tonya O Corbin,
Valerie C Reed,
Van Cliff,
Vlada Matusovsky,
Whitney S Reynolds,
William C Brenneman,
William J Muszynski,
William W Dotts,
Xinyi Hui,
Yessika Mashinski
Daniel W Johnson's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| April, 2014 | FDA 483 | Eugene Oregon, Inc. - Form 483, 2014-04-21 |
| February, 2015 | EIR | Laurence H. Belkoff D.O. - EIR, 2015-02-12 |
| October, 2015 | EIR | Dr. Eugene Andruczyk - EIR, 2015-10-22 |
| February, 2015 | FDA 483 | Laurence H. Belkoff D.O. - Form 483, 2015-02-12 |
| November, 2014 | FDA 483 | Custom Ultrasonics, Inc. - Form 483, 2014-11-19 |
| October, 2015 | FDA 483 | Dr. Eugene Andruczyk - Form 483, 2015-10-22 |
| June, 2015 | FDA 483 | Synergetics, Inc. - Form 483, 2015-06-09 |
| January, 2017 | EIR | AMAZON FULFILLMENT SVCS INC - EIR, 2017-01-05 |
| April, 2015 | FDA 483 | Custom Ultrasonics, Inc. - Form 483, 2015-04-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more